Non-Steroidal Anti-Inflammatory Drugs Market is estimated to be US$ 16.4 Billion by 2030 with a CAGR of 6.0% during the forecast period

Download Sample

Published Date: June 2023

The Non-Steroidal Anti-Inflammatory Drugs Market accounted for US$ 16.4 billion in 2020 and is estimated to be US$ 28.7 billion by 2030 and is anticipated to register a CAGR of 6.0%. Anti-inflammatory medications are prescribed to treat disorders such as asthma, arthritis, chronic obstructive pulmonary disorder (COPD), and others. The rising prevalence of these diseases is the primary driver of market growth. Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to treat pain and inflammation. These have become the most widely used medicines around the world as the number of prescriptions has increased. Because of three essential properties: analgesic, antipyretic, and anti-inflammatory, these are considered the first line of treatment in pain management. Nonsteroidal anti-inflammatory drugs (NSAIDs) have been used to treat pain since the 1960s and 1970s, when the FDA approved the first few main molecules including diclofenac and ibuprofen.

The report "Non-Steroidal Anti-Inflammatory Drugs Market, By type (paracetamol, Ibuprofen, aspirin, naproxen, and others), By disease indication (Arthritis, Migraine, ophthalmic and others), By Route of administration (Oral and Parenteral), By Application (hospital pharmacy, Retail pharmacy and online pharmacy) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Key Highlights:

Perrigo Company plc revealed in May 2019 that the U.S. FDA had approved an Abbreviated New Drug Application (ANDA) for Voltaren Gel.
Strides Pharma Inc. obtained FDA approval for Ibuprofen OTC Capsules in April 2018.

Analyst View:

The global demand for non-steroidal anti-inflammatory drugs is expected to expand rapidly in the coming years, owing to significant investments in product R&D. One of the major factors driving the growth of the non-steroidal anti-inflammatory drugs market is the rising prevalence of pain and inflammation-causing diseases. The use of these medications to treat acute and chronic pain is increasingly increasing. The demand for non-steroidal anti-inflammatory drugs is expected to rise due to rising prevalence of pain disorders, an increase in the geriatric population at high risk of various diseases, the acceptance of pain management therapeutics by end-users, and favourable regulatory and health-care reforms.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Non-Steroidal Anti-Inflammatory Drugs Market, By type (paracetamol, Ibuprofen, aspirin, naproxen, and others), By disease indication (Arthritis, Migraine, ophthalmic and others), By Route of administration (Oral and Parenteral), By Application (hospital pharmacy, Retail pharmacy and online pharmacy) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Key Market Insights from the report:

The Non Steroidal Anti Inflammatory Drugs market accounted for US$ 16.4 billion in 2020 and is estimated to be US$ 28.7 billion by 2030 and is anticipated to register a CAGR of 6.0%. The Non-Steroidal Anti-Inflammatory drugs Market is segmented based on the type, disease indication, route of administration, application, and region.

By type, the Non Steroidal Anti-Inflammatory drugs Market is segmented into paracetamol, Ibuprofen, Aspirin, Naproxen and others
By disease indication, the market is segmented in Arthritis, Migraine, Ophthalmic and others.
By route of administration, the market is segmented into oral and parenteral.
By Application, the Non steroidal Anti-inflammatory drugs Market is segmented into hospitals pharmacy, retail pharmacy and online pharmacy.
By region, the non-steroidal anti-inflammatory drugs Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe, on the other hand, is projected to continue to rise steadily, owing to favourable health reimbursement policies, a higher prevalence of migraine, and active government support

Competitive Landscape:

The key players operating in the non steroidal anti-inflammatory drugs market includes GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Pfizer Inc., Boehringer Ingelheim International GmbH, AstraZeneca, Bayer AG, Horizon Therapeutics plc, Zyla Life Sciences and other key players. GSK accounted for the largest share of the demand for non-steroidal anti-inflammatory drugs (NSAIDs). As several new players strive to enter the market through new product releases and strategic alliances, competition in the market is steadily growing.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period